• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
National Patterns of Commonly Prescribed Psychotropic Medications to Young People.青少年常用精神药物的全国使用模式。
J Child Adolesc Psychopharmacol. 2018 Apr;28(3):158-165. doi: 10.1089/cap.2017.0077. Epub 2018 Jan 29.
2
Stimulant Treatment of Young People in the United States.美国青少年的兴奋剂治疗
J Child Adolesc Psychopharmacol. 2016 Aug;26(6):520-6. doi: 10.1089/cap.2015.0228. Epub 2016 Mar 16.
3
Treatment of Young People With Antipsychotic Medications in the United States.美国青少年使用抗精神病药物的治疗情况。
JAMA Psychiatry. 2015 Sep;72(9):867-74. doi: 10.1001/jamapsychiatry.2015.0500.
4
Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.在需要后续使用非典型抗精神病药物与非抗精神病药物进行药物治疗的多动症患儿中,兴奋剂治疗的比较治疗模式、资源利用及成本。
J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89. doi: 10.18553/jmcp.2012.18.9.676.
5
Antipsychotic treatment of adults in the United States.美国成年人的抗精神病药物治疗。
J Clin Psychiatry. 2015 Oct;76(10):1346-53. doi: 10.4088/JCP.15m09863.
6
Trends in attention-deficit and hyperactivity disorder (ADHD) medications among children and young adults in Ireland: a repeated cross-sectional study from 2005 to 2015.爱尔兰儿童和青年人群中注意缺陷多动障碍(ADHD)药物使用趋势:2005 年至 2015 年的重复横断面研究。
BMJ Open. 2020 Apr 22;10(4):e035716. doi: 10.1136/bmjopen-2019-035716.
7
Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.抗精神病药物治疗注意缺陷/多动障碍青少年。
JAMA Netw Open. 2019 Jul 3;2(7):e197850. doi: 10.1001/jamanetworkopen.2019.7850.
8
Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.治疗患有注意力缺陷多动障碍的儿童和青少年的医生的护理提供与处方实践。
Psychiatr Serv. 2017 Jul 1;68(7):681-688. doi: 10.1176/appi.ps.201600130. Epub 2017 Feb 15.
9
National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.1996-2007 年,基于诊间的儿童和青少年精神科药物联用的全国趋势。
J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):1001-10. doi: 10.1016/j.jaac.2010.07.007. Epub 2010 Sep 1.
10
Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.患有注意力缺陷/多动障碍青少年的心理治疗药物使用模式
Arch Pediatr Adolesc Med. 1999 Dec;153(12):1257-63. doi: 10.1001/archpedi.153.12.1257.

引用本文的文献

1
Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children.一项公共资助的全民药物计划与儿童抗精神病药物和抗抑郁药物配药之间的关联。
BMC Pediatr. 2025 Feb 8;25(1):105. doi: 10.1186/s12887-024-05345-2.
2
Trends and Prevalence of Psychotropic Medication Use in Children and Adolescents in the Period Between 2013 and 2023: A Systematic Review.2013年至2023年期间儿童和青少年使用精神药物的趋势与流行情况:一项系统评价
Cureus. 2024 Mar 3;16(3):e55452. doi: 10.7759/cureus.55452. eCollection 2024 Mar.
3
Treatment Utilization Pattern of Preschool Children With Attention-Deficit/Hyperactivity Disorder.患有注意力缺陷/多动障碍的学龄前儿童的治疗利用模式。
J Atten Disord. 2024 Mar;28(5):708-721. doi: 10.1177/10870547231215287. Epub 2023 Dec 12.
4
Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses.氯胺酮辅助心理治疗用于患有多种精神疾病诊断的青少年。
Front Psychiatry. 2023 Mar 30;14:1141988. doi: 10.3389/fpsyt.2023.1141988. eCollection 2023.
5
Geographic variation and sociodemographic correlates of prescription psychotropic drug use among children and youth in Ontario, Canada: a population-based study.加拿大安大略省儿童和青少年处方精神药物使用的地域差异和社会人口学相关性:一项基于人群的研究。
BMC Public Health. 2023 Jan 11;23(1):85. doi: 10.1186/s12889-022-14677-6.
6
Evidence for machine learning guided early prediction of acute outcomes in the treatment of depressed children and adolescents with antidepressants.机器学习指导下抗抑郁药治疗抑郁儿童和青少年急性结局的早期预测证据。
J Child Psychol Psychiatry. 2022 Nov;63(11):1347-1358. doi: 10.1111/jcpp.13580. Epub 2022 Mar 15.
7
Serious Adverse Drug Reactions in Children and Adolescents Treated On- and Off-Label with Antidepressants and Antipsychotics in Clinical Practice.在临床实践中,儿童和青少年在标签内和标签外使用抗抑郁药和抗精神病药的严重药物不良反应。
Pharmacopsychiatry. 2022 Sep;55(5):255-265. doi: 10.1055/a-1716-1856. Epub 2022 Feb 7.
8
Preoperative Care Assessment of Need Scores Are Associated With Postoperative Mortality and Length of Stay in Veterans Undergoing Knee Replacement.术前护理需求评分与接受膝关节置换术的退伍军人术后死亡率和住院时间相关。
Fed Pract. 2021 Jul;38(7):316-324. doi: 10.12788/fp.0148.
9
A Retrospective Examination of the Impact of Pharmacotherapy on Parent-Child Interaction Therapy.药物治疗对亲子互动疗法影响的回顾性研究
J Child Adolesc Psychopharmacol. 2021 Dec;31(10):685-691. doi: 10.1089/cap.2021.0043. Epub 2021 Jul 28.
10
Development of a Symptom-Focused Model to Guide the Prescribing of Antipsychotics in Children and Adolescents: Results of the First Phase of the Safer Use of Antipsychotics in Youth (SUAY) Clinical Trial.开发以症状为导向的模型指导儿童和青少年抗精神病药物的处方:青少年安全使用抗精神病药物(SUAY)临床试验第一阶段的结果。
J Am Acad Child Adolesc Psychiatry. 2022 Jan;61(1):93-102. doi: 10.1016/j.jaac.2021.04.010. Epub 2021 May 4.

本文引用的文献

1
National Trends in the Prevalence and Treatment of Depression in Adolescents and Young Adults.青少年和青年抑郁症患病率及治疗的全国趋势。
Pediatrics. 2016 Dec;138(6). doi: 10.1542/peds.2016-1878. Epub 2016 Nov 14.
2
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.抗抑郁药治疗儿童和青少年重性抑郁障碍的疗效和耐受性比较:网状荟萃分析。
Lancet. 2016 Aug 27;388(10047):881-90. doi: 10.1016/S0140-6736(16)30385-3. Epub 2016 Jun 8.
3
Rapid Growth Of Antipsychotic Prescriptions For Children Who Are Publicly Insured Has Ceased, But Concerns Remain.公共医保儿童抗精神病药物处方的快速增长已停止,但担忧依然存在。
Health Aff (Millwood). 2016 Jun 1;35(6):974-82. doi: 10.1377/hlthaff.2016.0064.
4
Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review.青少年注意缺陷多动障碍的治疗:系统评价。
JAMA. 2016 May 10;315(18):1997-2008. doi: 10.1001/jama.2016.5453.
5
Gender differences in adult attention-deficit/hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).成人注意缺陷多动障碍的性别差异:来自国家酒精及相关疾病流行病学调查(NESARC)的结果
J Clin Psychiatry. 2016 Apr;77(4):e421-8. doi: 10.4088/JCP.14m09630.
6
Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.8岁儿童自闭症谱系障碍的患病率及特征——自闭症与发育障碍监测网络,美国11个地点,2012年
MMWR Surveill Summ. 2016 Apr 1;65(3):1-23. doi: 10.15585/mmwr.ss6503a1.
7
Stimulant Treatment of Young People in the United States.美国青少年的兴奋剂治疗
J Child Adolesc Psychopharmacol. 2016 Aug;26(6):520-6. doi: 10.1089/cap.2015.0228. Epub 2016 Mar 16.
8
A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia.一项评估抗精神病药物治疗早发性精神分裂症阳性和阴性症状相对疗效的系统评价和网状Meta分析。
CNS Drugs. 2016 Jan;30(1):27-39. doi: 10.1007/s40263-015-0308-1.
9
Treatment of Young People With Antipsychotic Medications in the United States.美国青少年使用抗精神病药物的治疗情况。
JAMA Psychiatry. 2015 Sep;72(9):867-74. doi: 10.1001/jamapsychiatry.2015.0500.
10
Trends in mental health care among children and adolescents.儿童和青少年心理健康护理的趋势。
N Engl J Med. 2015 May 21;372(21):2029-38. doi: 10.1056/NEJMsa1413512.

青少年常用精神药物的全国使用模式。

National Patterns of Commonly Prescribed Psychotropic Medications to Young People.

作者信息

Sultan Ryan S, Correll Christoph U, Schoenbaum Michael, King Marrisa, Walkup John T, Olfson Mark

机构信息

1 Department of Psychiatry, College of Physicians and Surgeons, New York State Psychiatric Institute, Columbia University , New York, New York.

2 Department of Psychiatry, The Zucker Hillside Hospital , Northwell Health, Glenn Oaks, New York.

出版信息

J Child Adolesc Psychopharmacol. 2018 Apr;28(3):158-165. doi: 10.1089/cap.2017.0077. Epub 2018 Jan 29.

DOI:10.1089/cap.2017.0077
PMID:29376743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5905871/
Abstract

OBJECTIVE

To describe national annual prescribing patterns of stimulant, antidepressant, and antipsychotic medications to young people.

METHODS

Prescriptions for three commonly prescribed psychotropic classes (stimulants, antidepressants, and antipsychotics) to young people aged 3-24 years were analyzed from the IMS LifeLink LRx National Longitudinal Prescription database (n = 6,351,482). Denominators were adjusted to generalize estimates to the U.S.

POPULATION

Comparisons are presented of percentages filling ≥1 prescription of each medication class during the study year stratified by patient sex, age, and prescriber specialty.

RESULTS

The total annual percentage of prescriptions filled by youth for any of the three medication classes was by age 3-5 years (0.8%), 6-12 years (5.4%), 13-18 years (7.7%), and 19-24 years (6.0%). Stimulant use was highest for older children (age 11 = 5.7%). Antidepressant use tended to increase with age and was highest for young adults (age 24 = 4.8%). Annual antipsychotic prescription percentages were lower than antidepressant or stimulant percentages for all age groups, with a peak in adolescence (age 16 = 1.3%). Annual stimulant and antipsychotic percentages for males were higher than corresponding percentages for females, but converged for young adults. Psychiatrists and child psychiatrists accounted for most of the prescriptions of antidepressants (22.2%-53.2%) and antipsychotics (51.7%-70%), but fewer of the stimulant prescriptions (30.4%-36.2%).

CONCLUSIONS

The age and sex distribution of stimulants and antidepressants among young people is broadly consistent with known epidemiologic patterns of their established indications for attention-deficit/hyperactivity disorder, anxiety, and depression. The pattern of antipsychotics may reflect the heterogeneity of disorders and conditions treated with this medication class.

摘要

目的

描述向年轻人开具兴奋剂、抗抑郁药和抗精神病药物的全国年度处方模式。

方法

从IMS LifeLink LRx全国纵向处方数据库(n = 6,351,482)中分析了向3至24岁年轻人开具的三种常用精神药物类别(兴奋剂、抗抑郁药和抗精神病药)的处方。分母进行了调整,以便将估计值推广到美国人口。

人群

按患者性别、年龄和开处方医生专业分层,比较了在研究年度内每种药物类别开具≥1张处方的百分比。

结果

这三种药物类别中任何一种的年轻人年度处方总百分比在3至5岁为(0.8%),6至12岁为(5.4%),13至18岁为(7.7%),19至24岁为(6.0%)。年龄较大的儿童(11岁 = 5.7%)使用兴奋剂的比例最高。抗抑郁药的使用倾向于随年龄增加,在年轻人中最高(24岁 = 4.8%)。所有年龄组的年度抗精神病药物处方百分比均低于抗抑郁药或兴奋剂百分比,在青春期达到峰值(16岁 = 1.3%)。男性的年度兴奋剂和抗精神病药物百分比高于女性的相应百分比,但在年轻人中趋于一致。精神科医生和儿童精神科医生开具的抗抑郁药(22.2% - 53.2%)和抗精神病药(51.7% - 70%)处方占大多数,但兴奋剂处方较少(30.4% - 36.2%)。

结论

年轻人中兴奋剂和抗抑郁药的年龄和性别分布与已知的注意力缺陷/多动障碍、焦虑症和抑郁症既定适应症的流行病学模式大致一致。抗精神病药物的模式可能反映了该药物类别所治疗疾病和病症的异质性。